Drawing for IMPACT IONO-METALLIC PATHOGEN AGNOSTIC COMBINATION THERAPY

USPTO serial 99161023

IMPACT IONO-METALLIC PATHOGEN AGNOSTIC COMBINATION THERAPY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MARTYNOV, VIKTORIIA V
Law office
TMO LAW OFFICE 133

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with IMPACT IONO-METALLIC PATHOGEN AGNOSTIC COMBINATION THERAPY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kristen Ruisi

Kristen Ruisi Venable LLP151 West 42nd Street, 49th FloorNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of blood-borne pathogens and diseases caused thereby; pharmaceutical preparations for the treatment of viruses, bacteria and other pathogenic organisms and diseases caused therebyACTIVE—
010Medical devices for use in treating infectionsACTIVE—
042Providing medical and scientific research information in the field of health and pharmaceuticals on the internet; Research and development of new products for others; Research and development services, namely conducting research focused on the fight against antimicrobial resistance (AMR) and for the treatment of blood-borne pathogens and diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jan 27, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 27, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 1, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Oct 1, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jul 1, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2025DOCKASSIGNED TO EXAMINER—
Jun 12, 2025MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jun 12, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 29, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 29, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance